- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Latest Conference Articles
The OncLive® Conference page includes a listing of all conferences covered by OncLive®, including the ASCO, ESMO, SITC, EHA, ASH, and SABCS annual meetings, as well as the Chemotherapy Foundation Symposium and Miami Breast Cancer Conference, among many others. Conference coverage incorporates articles and interviews in written and video format.
Early Palliative Care for Caregivers Improves Their Wellbeing, Too
May 31st 2014, 9:21am
A phone-based intervention that offers practical tools to help family caregivers support their loved one with advanced cancer-as well as emphasizing the importance of maintaining a healthy lifestyle themselves-resulted in less caregiver depression and better quality of life, according to the findings of a new study presented May 30 at the 50th Annual ASCO Meeting in Chicago.
Zoledronic Acid Can Be Administered Less Frequently in Breast Cancer
May 31st 2014, 9:16am
The dosing frequency of zoledronic acid can be reduced by 67% without compromising efficacy and safety in women with breast cancer and bone metastases.
Dr. Hussain on ETS Gene Fusions as a Predictive Biomarker in Prostate Cancer
May 31st 2014, 8:16am
Maha Hussain, MD, from the University of Michigan Comprehensive Cancer Center, discusses the possibility of ETS gene fusions acting as a predictive biomarker for prostate cancer.
Reducing Pills From the Cup: Discontinuing Statins in Late-Stage Cancer Patients
May 31st 2014, 6:01am
For patients with less than a year to live, the discontinuation of statins may increase the median time-to-death and improve quality of life.
Dr. Formenti on Concurrent Adjuvant Systemic Therapy and Accelerated Radiotherapy in TNBC
May 29th 2014, 1:16pm
Silvia Formenti, MD, The Sandra and Edward H. Meyer Professor of Radiation Oncology chair, Radiation Oncology, NYU Langone Medical Center, associate director, Radiation Oncology, Perlmutter Cancer Center at NYU Langone, discusses a trial that examines concurrent adjuvant systemic therapy and accelerated radiotherapy in triple-negative breast cancer (TNBC)
Dr. Pavlick on a Phase II Trial of Cyclophosphamide and Ipilimumab in Melanoma
May 28th 2014, 11:24am
Anna C. Pavlick, DO, associate professor, Hematology and Medical Oncology, medical director, Clinical Trials Office, Perlmutter Cancer Center at NYU Langone, discusses a phase II trial exploring low-dose cyclophosphamide and ipilimumab in metastatic melanoma.
Dr. Luke Discusses the Phase III COMBI-d Trial Results
May 24th 2014, 5:26am
Jason J. Luke, MD, instructor, Department of Medicine, Harvard School of Medicine, staff physician, medical oncologist- melanoma, Dana-Farber Cancer Institute, discusses the controversy behind the COMBI-d trial results.
Dr. Shore on a Long-Term Safety Analysis of the COU-AA-302 Study
May 23rd 2014, 10:36am
Neal D. Shore, MD, FACS, medical director, Carolina Urologic Research Center, Myrtle Beach, discusses a long-term safety analysis of the COU-AA-302 study, which he presented at the 2014 AUA Annual Meeting.
Dr. Kapoor Discusses the Inclusion of Radium-223 in AUA Guidelines for CRPC
May 21st 2014, 8:27am
Deepak A. Kapoor, MD, from Integrated Medical Professionals, PLLC, discusses the inclusion of radium-223 in the AUA guideline for castration resistant prostate cancer (CRPC).
PSA Growth Rate May Help Identify Aggressive Prostate Cancer Early
May 21st 2014, 6:33am
Analysis of trends in prostate-specific antigen (PSA) dynamics suggested that PSA growth rates, as well as the amount of PSA-level increase due specifically to cancer, might offer a means of distinguishing aggressive, potentially fatal prostate cancer from clinically inconsequential tumors.
Dr. Evans Discusses the Subgroup Analysis Results of the PREVAIL Study
May 20th 2014, 11:14am
Christopher P. Evans, MD, professor, chairman, Department of Urology, University of California at Davis School of Medicine, UC Davis Comprehensive Cancer Center, discusses the results of an analysis of patients with and without visceral disease defined as liver and/or lung metastases who participated in the PREVAIL study.
Intermittent Degarelix Effective With Less Metabolic Syndrome Than Hormone Agonists, Studies Suggest
May 20th 2014, 10:15am
Men given the GnRH antagonist degarelix because their PSA level rose after primary therapy fared at least as well on an intermittent medication schedule as on a continuous schedule
Cell-Cycle Gene Test Shows Early Promise in Clear Cell RCC
May 20th 2014, 8:20am
A cell-cycle gene array test demonstrated independent value for predicting metastatic progression after surgery for organ-confined renal cell carcinoma (RCC) of clear cell histology, a retrospective study of patient data showed.
Dr. Crawford on Intermittent Androgen Deprivation With Degarelix
May 20th 2014, 6:26am
E. David Crawford, MD, from University of Colorado at Denver, discusses a study presented at the 2014 AUA Annual Meeting that analyzed intermittent androgen deprivation with degarelix.
ED Therapy May Preserve Function, Penile Length After Prostatectomy
May 19th 2014, 12:16pm
Daily treatment with the PDE-5 inhibitor tadalafil (Cialis) led to a significant decrease in loss of penile length among men who had undergone bilateral nerve-sparing radical prostatectomy.
Testicular Self-Examination Cost-Effective Compared with Missed Advanced Cancer
May 19th 2014, 6:01am
Testicular self-examination remains highly cost-effective despite a negative recommendation from the United States Preventive Services Task Force (USPSTF), a cost-utility analysis suggested.
In Dog Study, Prostate Cancer Found With a Whiff and a Woof
May 19th 2014, 5:31am
When it comes to detecting prostate cancer accurately and noninvasively, dogs may be ahead by a nose.
Dr. Aberger Discusses a Cost Analysis of Testicular Self-Examinations
May 18th 2014, 11:31am
Michael Aberger, MD, resident physician, University of Kansas Medical Center, discusses a cost analysis of testicular self-examinations.
Social Media Vital in Marketing Large Urology Practices
May 18th 2014, 7:57am
In the age of social media, simply having a website isn't enough. To keep existing patients and attract new ones, large urology group practices need to build websites that are connected to social media outlets at every turn, said Peter M. Knapp, Jr, MD.
Physical Activity Linked to Lower Risk of Death from Bladder Cancer
May 18th 2014, 7:19am
Self-reported physical activity significantly improved the odds that a person would not die of bladder cancer, a review of a national health information database showed.